Evidence map›Paper›PMID 39694764›Full record

ArticleHematology, transfusion and cell therapy2024

Management of febrile neutropenia: consensus of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy - ABHH.

Marcio Nucci, Celso Arrais-Rodrigues, Maria Daniela Bergamasco, Marcia Garnica, Ana Beatriz Firmato Gloria, Mariana Guarana, Clarisse Machado, Jessica Ramos, Marco Aurelio Salvino, Belinda Simões

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Hematology, transfusion and cell therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Management of Febrile Neutropenia in a Tropical Country.Hematology, transfusion and cell therapy · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marcio NucciDepartment of Internal Medicine, Hospital Universitário, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil; Grupo Oncoclinicas, Rio de Janeiro, Brazil. Electronic address: mnucci@hucff.ufrj.br.
Celso Arrais-RodriguesDepartment of Clinical and Experimental Oncology, Universidade Federal de São Paulo (Unifesp), São Paulo, Brazil; Hospital Nove de Julho, Rede DASA, São Paulo, Brazil.
Maria Daniela BergamascoHospital Israelita Albert Einstein, São Paulo, Brazil.
Marcia GarnicaDepartment of Internal Medicine, Hospital Universitário, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil; Complexo Hospitalar de Niterói - CHN-DASA, Niterói, Brazil.
Ana Beatriz Firmato GloriaDivisão de Hematologia da Federal da Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil; Grupo Oncoclínicas, Belo Horizonte, Brazil.
Mariana GuaranaHospital Universitário Gaffrée e Guinle, Universidade Federal do Estado do Rio de Janeiro (HUGG UFRJ), Rio de Janeiro, Brazil.
Clarisse MachadoInstituto de Medicina Tropical da Universidade de São Paulo (IMT USP), São Paulo, Brazil; Programa de Transplante de Células Hematopoiéticas do Hospital Amaral Carvalho, Jaú, Brazil.
Jessica RamosHospital Sírio-Libanês, São Paulo, Brazil.
Marco Aurelio SalvinoPPGMS Universidade Federal da Bahia, Salvador, Bahia, Brazil.
Belinda SimõesDepartment of Medical Images, Hematology and Clinical Oncology, Ribeirão Preto Medical School - University of São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Febrile neutropenia is a major complication of the treatment of patients with hematologic diseases. Recent epidemiologic changes, with an increase in infection caused by drug-resistant bacteria, represent a major challenge for the proper management of febrile neutropenia. The impact of these changes in the epidemiology of infection may vary according to the region. In this document we present recommendations from the Infectious Diseases Committee of the Brazilian Association of Hematology, Blood Transfusion and Cell Therapy (ABHH) for the management of febrile neutropenia in hematologic patients. The consensus was developed by ten experts in the field, using the Delphi methodology. In the document we provide recommendations for the initial workup, prophylaxis, empiric antibiotic and antifungal therapy, modifications in the empiric regimen and criteria for discontinuing antimicrobial therapy.

Indexed as

ConsensusFebrile neutropeniaManagementNeutropeniaTreatment

Identifiers

PMID39694764
PMCPMC11726106

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.